Cello Health (CLL)

Sector:

Health Care

Index:

FTSE AIM All-Share

113.00p
   
  • Change Today:
      4.00p
  • 52 Week High: 148.50
  • 52 Week Low: 101.00
  • Currency: UK Pounds
  • Shares Issued: 106.23m
  • Volume: 780,640
  • Market Cap: £120.04m
  • RiskGrade: 281

Deal with Barclays    Trade now with Barclays Stockbrokers

Cello Health Overview

Cello Health is in the health care sector and is currently trading at 113.00p per share. In the last year Cello Health's share price has ranged from 101.00p to 148.50p and brokers are currently rating this stock as 'buy'.

Key Personnel

CEO: Mark Scott
Executive Director: Julia Ralston
Group COO: Stephen Highley
Group Finance Director: Mark Bentley
Independent Non-Executive Director: Jo LeCouilliard
Independent Non-Executive Director: Clifford Tompsett
Non-Executive Chairman: Christopher Jones
Non-Executive Dir: Michele Luzi

Contact Details

Address: Queens House, 8-9 Queen Street, London, United Kingdom, EC4N 1SP
Phone: +44 (0)20 7812 8460
Fax: +44 (0)20 7253 5376

Listings

Sector: Health Care(LSE)
Index: FTSE AIM All-Share
ISIN: GB00B0310763

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Cello Health Market Data

Currency UK Pounds
Share Price 113.00p
Change Today 4.00p
% Change 3.67 %
52 Week High 148.50
52 Week Low 101.00
Volume 780,640
Shares Issued 106.23m
Market Cap £120.04m
RiskGrade 281

Cello Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.51% below the market average66.51% below the market average66.51% below the market average66.51% below the market average66.51% below the market average
67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average67.57% above the sector average
Price Trend
46.34% above the market average46.34% above the market average46.34% above the market average46.34% above the market average46.34% above the market average
7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average7.32% above the sector average
Income
9.26% below the market average9.26% below the market average9.26% below the market average9.26% below the market average9.26% below the market average
86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average86.67% above the sector average
Growth
40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average40.89% below the market average
44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average44.44% below the sector average

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 2
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Cello Health Dividends

  Latest Previous
  Final Interim
Ex-Div 23-Apr-20 03-Oct-19
Paid 22-May-20 01-Nov-19
Amount 2.95p 1.15p

Trades for 31-Mar-2020

Time Volume / Share Price
17:00 5,000 @ 112.00p
16:20 213 @ 114.00p
15:20 40,000 @ 113.00p
15:52 458 @ 113.30p
15:46 458 @ 113.30p

Cello Health Key Personnel

CEO Mark Scott

Top of Page